- Report
- March 2024
- 184 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- May 2024
- 93 Pages
Global
From €5393EUR$5,600USD£4,638GBP
- Report
- November 2023
- 1300 Pages
Global
From €9625EUR$9,995USD£8,278GBP
- Report
- June 2023
- 1041 Pages
Europe
From €8662EUR$8,995USD£7,450GBP
- Report
- February 2020
- 25 Pages
United States
From €951EUR$988USD£818GBP
€1902EUR$1,975USD£1,636GBP
- Report
- April 2018
- 226 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- July 2022
- 100 Pages
Global
From €2648EUR$2,750USD£2,278GBP
- Report
- April 2023
- 112 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- October 2023
- 146 Pages
Global
From €3397EUR$3,528USD£2,922GBP
€3996EUR$4,150USD£3,437GBP
The Cardiovascular Patch market is a subset of the Cardiovascular Devices market, which includes a variety of medical devices used to diagnose and treat cardiovascular diseases. Cardiovascular Patches are adhesive patches that are placed on the skin to monitor and treat cardiovascular conditions. These patches are designed to be worn for extended periods of time and can measure a variety of vital signs, such as heart rate, blood pressure, and oxygen saturation. They can also be used to deliver medications or other treatments directly to the skin.
Cardiovascular Patches are becoming increasingly popular due to their convenience and accuracy. They are also being used in clinical trials to evaluate the effectiveness of new treatments and medications.
Some of the companies in the Cardiovascular Patch market include Abbott, Medtronic, Philips, and Johnson & Johnson. Show Less Read more
